Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-28 @ 10:45 PM
Study NCT ID:
NCT00730158
Status:
COMPLETED
Last Update Posted:
2019-05-22
First Post:
2008-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Sponsor:
Edward Chu, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-04
First Submit QC Date:
None
Study First Post Date:
2008-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-15
Results First Submit QC Date:
None
Results First Post Date:
2019-05-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-29
Last Update Post Date:
2019-05-22
Last Update Post Date Type:
ACTUAL